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Abstract 
Background: The burden of cardiometabolic diseases, including 
cardiovascular diseases and diabetes, is increasing in sub-Saharan 
Africa and this has been linked to urbanisation. Helminths, through 
their immunomodulatory properties, may protect against these 
disorders. We hypothesised that the rural environment protects 
against cardiometabolic diseases and that helminths may influence 
rural-urban disparity of cardiometabolic disease risk. 
Methods: We compared metabolic parameters of individuals aged 
≥10 years living in rural, high-helminth-transmission and urban, 
lower-helminth-transmission settings in Uganda. Cross-sectional 
surveys were conducted in rural Lake Victoria island fishing 
communities and in urban sub-wards in Entebbe municipality. 
Helminth infection and outcomes, including insulin resistance 
(computed using the homeostatic model assessment of insulin 
resistance [HOMA-IR]), fasting blood glucose, fasting blood lipids, 
blood pressure, body mass index (BMI), waist and hip circumference, 
were assessed. 
Results: We analysed 1,898 rural and 930 urban participants. 
Adjusting for BMI, exercise, smoking, alcohol intake, age and sex, 
urban residents had lower mean fasting glucose (adjusted mean 
difference [95%CI] 0.18 [-0.32, -0.05] p=0.01) and HOMA-IR (-0.26 [-
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0.40, -0.11] p=0.001) but higher blood pressure (systolic, 5.45 [3.75, 
7.15] p<0.001; diastolic, 1.93 [0.57, 3.29] p=0.006). Current helminth 
infection did not explain the observed differences. 
Conclusions: In the Ugandan context, living in rural fishing 
communities may protect against hypertension but worsen glucose 
metabolism.
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Introduction
Globally, non-communicable diseases (NCDs) are the leading 
cause of mortality and disability. In 2016, they contributed to 
72.3% of deaths1, and cardiometabolic disorders were the top 
contributors to disability adjusted life years2. The World Health 
Organisation (WHO) estimates that 78% of NCD related deaths 
occur in low and middle income countries and that the NCD 
burden is rapidly increasing in these countries3. Sub-Saharan 
Africa, a region undergoing rapid economic growth, is experi-
encing this epidemiological transition, with the double burden of 
NCDs and communicable diseases.
The increased NCD burden has been linked to urbanisation and, 
currently, more than half of the world’s population lives in urban 
areas4. Urban living is associated with traditional risk factors 
for cardiometabolic disease such as diets rich in energy-dense 
foods and reduced physical activity. This may suggest that the 
rural environment is protective against cardiometabolic diseases 
and various data sources confirm this5–7. However, there are 
reports of an increasing or already high burden of NCDs such 
as hypertension and diabetes in rural areas8–10 and no differ-
ence in burden between urban and rural settings11. An increase in 
body mass index in rural areas has been identified as the main 
driver of the global epidemic of obesity12.
The hygiene hypothesis proposes that the increase in chronic 
inflammatory disorders in high-income countries is linked to 
cleaner environments and less exposure to infectious agents13. 
Exposure to infectious agents such as helminths modulates 
the immune system and may provide protection against these 
disorders. The urban environment is associated with less 
exposure to helminths compared to the rural environment. 
Recently, chronic inflammation has been linked to the aetiol-
ogy of cardiometabolic disorders such as type 2 diabetes14 and 
atherosclerosis15, and has been proposed to have a role in essen-
tial hypertension16. It remains unclear whether reduced exposure Figure 1. Location of the study areas.
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We thank the reviewers for the insightful comments. Based 
on the comments, we have made changes to and updated 
our article. In the abstract, the conclusion has been refined 
to make it more specific. To explain the difference in fasting 
glucose between the urban and rural settings, we have included 
pancreatic beta cell function as an outcome and reported 
the results. Occupation, as a possible proxy for activity levels, 
was added to the adjusted models and the new results from 
the analyses are presented in Table 2 and Table 3. To further 
explore the role helminths in any observed differences in 
metabolic outcomes, the impact of S. mansoni infection intensity 
was analysed and the results are shown in Table 5. In the 
discussion, we made changes to highlight the relatively young 
study population and incorporated our previous trial findings. 
Furthermore, we included the possibility of non-compliance 
to overnight fasting and emphasised the role of diet and 
socioeconomic status in partially explaining the differences 
observed in the two settings.
Any further responses from the reviewers can be found at 
the end of the article
REVISED
to helminth infections has contributed to the increase, and 
rural-urban differences, in cardiometabolic disease. There is evi-
dence from animal studies, and the few published human stud-
ies, that through their effects on inflammation and metabolism, 
helminth infections are associated with favourable metabolic 
outcomes17–19.
We therefore tested the hypothesis that the rural environment 
is protective against metabolic risk factors and diseases and 
that helminths play a role in this. We investigated differences 
in metabolic parameters between a rural, high helminth trans-
mission setting and an urban, lower helminth transmission 
setting in Uganda. We also investigated whether helminths 
might explain any differences observed between the two settings.
Methods
Study design and setting
We conducted parallel cross-sectional surveys, one in a rural 
and one in an urban setting (Figure 1). The rural survey was the 
metabolic outcomes survey of the Lake Victoria Island Interven-
tion Study on Worms and Allergy-related diseases (LaVIISWA). 
LaVIISWA was a cluster-randomised trial investigating the 
effects of intensive versus standard anthelminthic interven-
tion on health outcomes in 26 rural Lake Victoria island 
communities of Koome sub-county, Mukono district, Uganda 
(population, 18,778)20,21. The metabolic outcomes survey was 
conducted between April and November 2017 after four years 
of the anthelminthic intervention22. The survey in the urban set-
ting was deliberately formulated to collect data in parallel with 
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the LaVIISWA outcome surveys to enable rural-urban compari-
son of allergy-related23,24 and metabolic outcomes. It was con-
ducted in Entebbe municipality, Wakiso district, Uganda from 
September 2016 to September 2017. Entebbe municipality is 
classified by the Uganda Bureau of Statistics as an urban area25, 
and is located on the northern shores of Lake Victoria, with 
a population of 69,958 residing in 24 sub-wards (the smallest 
administrative units)25.
Participants
Household surveys were conducted in both settings. 
Households with members available at the time of conducting 
the surveys were eligible for inclusion. In the rural setting, the 
study team, in collaboration with the local leaders, maintained 
an updated register of all the households in the 26 study vil-
lages. This was used as a sampling frame to randomly select 70 
households in each of the 26 study villages using Stata software 
(College Station, Texas, USA). In the urban setting, a different 
sampling technique was used because resources and time could 
not permit a complete household listing before starting the survey. 
With the help of locally available maps, we mapped each 
sub-ward onto satellite imagery of the area excluding areas that 
were uninhabited. The mapped sub-wards were then divided into 
segments of equal geographical size based on lines of latitude and 
longitude (degrees, minutes, seconds position format) and each 
segment was numbered. Using random number generation, seg-
ments were randomly selected from each sub-ward. The number 
of segments selected was proportional to the population size of 
the sub-ward. The midpoint of each selected segment was 
identified by its coordinates using a using a geographic infor-
mation system (GIS) device (eTrex®, Garmin™ Ltd, Kansas, 
United  States). This was used as the starting point for sampling 
households and the nearest house was selected for inclusion. Houses 
were then sequentially selected, the next house to be sampled 
being the nearest to the previous house. In total, 120 geographi-
cal segments were targeted in the 24 sub-wards and in each 
segment, four households were targeted. If a household was 
empty or refused, the next one was approached until the number 
per segment was completed.
In both surveys, a household was defined as a habitable roofed 
structure whose primary function was residence or, if used 
for dual purposes, had at least one active resident using the struc-
ture as their primary residence. In selected and participating 
households, permission was sought from the household head 
or another adult in the household if the household head was 
absent. Households where all members refused to participate, or 
where all members were absent during the survey period, were 
excluded. All survey questions are described in the Codebook 
of the Underlying data26.
Variables
The exposure variables were the rural/urban setting and 
helminth infection status. The outcomes were insulin resistance 
(measured using the homeostatic model assessment of insulin 
resistance (HOMA-IR; HOMA-IR = fasting serum insulin x fast-
ing glucose / 22.5), fasting blood glucose, total cholesterol, trig-
lyceride levels, High Density Lipoprotein (HDL) - cholesterol and 
low density lipoprotein (LDL) – cholesterol, blood pressure, 
body mass index (BMI), waist and hip circumference. Follow-
ing a reviewer’s suggestion, we also included mean pancreatic 
beta cell function (HOMA-B) as an outcome. HOMA-B was 
calculated using the formula, HOMA-B=(20 × fasting insulin 
(μIU/ml)/fasting glucose (mmol/ml) − 3.5)].
Data sources/ study procedures
The tools and procedures of both surveys were aligned to allow 
comparison of the metabolic outcomes data between urban and 
rural settings. A questionnaire was administered to consent-
ing household members. With this questionnaire, data were 
collected on household and individual sociodemographic char-
acteristics as well as information on lifestyle, exercise or 
vigorous physical activity, diet, history of diabetes and 
hypertension.
A physical examination was performed and information obtained 
on blood pressure, weight, height, waist and hip circumfer-
ence. With the participant seated, rested and comfortable, blood 
pressure was measured using a digital sphygmomanometer 
(OMRON Model M2[hem-7121-E], Omron Health Care, Kyoto, 
Japan). Three blood pressure measurements were taken five min-
utes apart, with the average of the last two measurements used 
for the analysis. A portable, flat digital weighing scale (SECA 
model 875 7021094, Hamburg, Germany) was used to take 
two measurements of body weight for each participant and the 
average of the two readings computed and used in the analysis. 
Height was measured using a stadiometer (SECA model 
213 1721009, Hamburg, Germany) and recorded to the nearest 
millimetre. Two readings were obtained and the mean was used 
in the analysis. Quality control checks, using standard calibration 
rods for the stadiometers and standard weights for the weigh-
ing scales, were performed at the beginning of each working 
day. The sphygmomanometers were calibrated by the Uganda 
Bureau of Standards.
After an overnight fast, participants provided venous blood 
samples. The tests carried out on these samples included fast-
ing blood glucose, insulin, fasting lipid profile and hae-
moparasitology. Fasting blood glucose, insulin and fasting 
lipid profile were tested using the COBAS cobas 6000 analyser 
(cobas c 501 module, Roche Diagnostics, Rotkreuz, Switzer-
land). Mansonella perstans was tested using the modified Knott’s 
method27.
Each participant was requested to provide one stool sample. 
Duplicate slides were made from each sample and the slides 
independently examined using the Kato Katz technique28 by 
experienced technicians. Additionally, real-time stool polymer-
ase chain reaction (PCR) was used to detect Schistosoma 
mansoni, Necator americanus and Strongyloides stercoralis29,30.
Diabetes and impaired fasting glucose were defined, accord-
ing to the WHO classification, as fasting plasma glucose of 
≥7.0 mmol/L and 6.1–6.9 mmol/L, respectively31,32. Hyperten-
sion was defined as diastolic blood pressure of ≥90 mmHg or 
systolic blood pressure of ≥140 mmHg in participants 
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≥18 years of age33. Participants <18 years old were categorised 
to be hypertensive if their systolic or diastolic blood pressures 
were above the 95th percentile using the Centers for Disease 
Control blood pressure charts for children and adolescents34.
Sample size
In the rural setting, we aimed to recruit 1950 participants (sam-
pling 70 households without replacement was expected to yield 
75 participants aged ≥10 years from each of the 26 villages). 
This number was primarily calculated for the LaVIISWA trial 
analysis and was estimated to give 80% power to detect a differ-
ence in mean HOMA-IR of 0.05 between the trial arms assum-
ing an intra-cluster correlation coefficient of 0.03 and a standard 
deviation on the log scale of 0.2. In the urban survey, we 
targeted a sample size of 960 individuals aged ten and over, and 
estimated that this would allow us to detect an absolute differ-
ence of 0.03 in mean HOMA-IR between urban and rural settings, 
assuming a standard deviation on the log scale of 0.2, and a 
design effect of 1.5. Assuming a 13% failure rate in household 
response and an average of around 2.3 individuals aged 
≥10 years per household 480 households were targeted.
Statistical methods
The statistical analyses were performed using Stata version 13.0 
(College Station, Texas, USA). We tabulated the characteristics of 
households and individuals in the urban setting alongside those 
of the rural setting in order to see how these differed between 
the two settings. We compared the outcomes between the rural 
setting and the urban setting. We summarised the mean for each 
outcome in the two settings and then assessed for differences 
by fitting regression models for each outcome that included 
a random effect to allow for the clustering (by village for the 
rural setting, by sub-ward for the urban setting) and a binary 
covariate that denoted whether the individual is in the urban or 
rural setting. Crude and adjusted mean differences and 95% con-
fidence intervals are presented. All the outcomes were initially 
adjusted for age and sex and further adjusted for occupation, 
exercise, alcohol intake and smoking. HOMA-IR, fasting glu-
cose, triglycerides, LDL-cholesterol, HDL-cholesterol, systolic 
and diastolic blood pressure were additionally adjusted for BMI. 
We did not perform any adjustments for multiple testing. In all 
analyses, data from the rural setting comprised all participants 
regardless of whether they had received intensive or standard 
anthelminthic treatment, i.e. both arms of the LaVIISWA trial 
were included. This was done because there were no strong 
differences in the outcomes between the trial arms22.
To investigate whether helminths influence the differences 
observed in the metabolic outcomes, each helminth variable was 
added separately to the model and any change in the mean differ-
ence, confidence interval and p-values were assessed. Helminths 
were considered to have an influence on the urban-rural differ-
ences if addition of the variable resulted in a substantial change 
in the mean difference.
Ethical approval and consent
Ethical approval was granted by the Uganda Virus Research 
Institute Research Ethics committee (reference number 
GC/127/17/01/573), the Uganda National Council for Science and 
Technology (reference number HS 2185) and the London School 
of Hygiene and Tropical Medicine (reference number 9917). 
Permission to conduct the surveys was granted by the local lead-
ership of Mukono district (for the rural survey) and Entebbe 
municipality (for the urban survey). All participating adults and 
emancipated minors provided written informed consent. Par-
ticipants aged 10 to 17 years provided assent and their parents/ 
guardians provided written informed consent.
Results
Participants
The survey flow is shown in Figure 2. In the rural setting, 2167 
individuals aged 10 years and above from 1271 households 
were eligible for participation. Of these, 1898/2167 (87.6%) 
consented and provided data. In the urban setting, 1124 individu-
als from 416 households were eligible and 930/1124 (82.7%) 
consented and provided data. One sub-ward was a military 
facility and could not be surveyed because the study team was 
not granted access. In both surveys, the main reasons for non- 
participation were absenteeism (180/2167;8.3% in the rural 
setting and 165/1124;14.7% in the urban setting) and refusal 
(80/2167;3.7% in the rural setting and 18/1124;1.6% in the urban 
setting). Individual-level demographic data and survey responses 
are available as Underlying data26.
Descriptive data
The characteristics of the study participants are shown in 
Table 1. Male participants constituted approximately half (51%; 
1010/1890) and 35% (322/920) of the participants in the rural 
and urban survey respectively. The mean age of the participants 
was 31.5 years in the rural setting and 29.7 years in the urban 
setting. In the rural survey, the main economic activity was 
fishing (739/1898;37.9%) while in the urban setting most par-
ticipants were involved in service provision, were artisans or had 
shops and salons (211/917;23.9%). The rural population was 
more physically active with 49.3% (920/1868) reporting exercise 
or vigorous physical activity at least once a week compared 
to 16.6% (152/914) in the urban setting. More participants in 
the rural setting reported having ever smoked (343/1868;18.3% 
vs 38/914;4.2%) or taken alcohol (905/1868;47.5% vs 
187/914;20.5%) compared to those in the urban setting.
The rural participants had more exposure to the lake with 67.5% 
(1309/1857) reporting daily lake contact compared to only 
3.3% (30/916) in the urban setting. Regarding anthelminthic 
treatment, 86.9% (1661/1896) of participants in the rural set-
ting reported having ever received treatment for worms com-
pared to 72.8% (646/888) of urban participants. Of these, 67.2% 
(1113/1604) in the rural setting reported having been treated with 
praziquantel in the last 12 months compared to 3.0% (19/639) 
in the urban setting. Helminth prevalence was higher in the rural 
setting with a significantly higher prevalence of S. mansoni 
(stool Kato Katz, 31.7% vs 9.9%, p<0.001; stool PCR 47.6% vs 
22.2%, p<0.001), Trichuris trichiura (stool Kato Katz, 6.9% vs 
2.2%, p=0.002) and Strongyloides stercoralis (stool PCR, 6.1% 
vs 3.2%, p=0.026). In both settings, most of the S. mansoni 
infections were of light intensity.
Rural-urban differences in metabolic outcomes
The metabolic outcomes measured in both settings are shown 
in Table 2. Mean fasting glucose was higher in the rural setting 
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Table 1. Characteristics of participants in the rural and urban settings.
Household-level characteristics
Rural setting 
n/N (%)
Urban 
setting 
n/N (%)
P 
value*
Total number of households participating in 
the survey 1271 416
Household size (median, IQR) 2 (1,3) 4 (2,5)
Individual-level characteristics
Sex, male 1010/1898 (51.2) 322/920 (35.0) <0.001
Age
Age in years (mean, SD) 31.5 (11.0) 29.7 (15.0) 0.003
Age in years, grouped
            10–19 215/1898 (11.8) 261/920 (28.4) <0.001
            20–29 648/1898 (33.7) 298/920 (32.4)
            30–39 594/1898 (30.7) 164/920 (17.8)
            40+ 441/1898 (23.7) 197/920 (21.4)
Occupation
            Child/student 121/1898 (7.2) 253/917 (27.6) <0.001
            Housewife 199/1898 (9.7) 166/917 (18.0)
            Fishing or lake related 739/1898 (37.9) 17/917 (1.9)
             Shops, salons, artisans, service 
providers 214/1898 (13.0) 211/917 (23.9)
             Bars, restaurants, food providers, 
entertainment 160/1898 (8.4) 48/917 (5.2)
            Agriculture, lumbering, charcoal 396/1898 (19.2) 35/917 (3.8)
            Professional 33/1898 (2.3) 37/917 (4.0)
            Unemployed 36/1898 (2.4) 128/917 (14.0)
            Other (not specified) 0 22/917 (2.4)
Figure 2. Study flow chart.
Page 6 of 29
Wellcome Open Research 2020, 5:39 Last updated: 25 AUG 2020
Household-level characteristics
Rural setting 
n/N (%)
Urban 
setting 
n/N (%)
P 
value*
Residence
Always lived in the study area 164/1898 (8.6) 454/919 (49.4) <0.001
Place of birth
            Village 1716/1898 (90.2) 318/918 (34.6) <0.001
            Town or city 182/1898 (9.8) 600/918 (65.4)
First five years
            Village 1700/1885 (89.8) 339/918 (36.9) <0.001
            Town or city 185/1885 (10.2) 579/918 (63.1)
Age of participant when he/she moved to this 
village (mean, SD) 23.0 (11.2) 22.8 (11.3) 0.388
Parental tribe
Maternal tribe region of origin
            Central 678/1898 (36.7) 400/918 (43.5) 0.097
            Western 294/1898 (15.3) 190/918 (20.7)
            Eastern 405/1898 (21.0) 131/918 (14.3)
            Northern 202/1898 (10.1) 110/918 (12.0)
            Non-Ugandan 311/1898 (16.6) 81/918 (8.8)
            Do not know 8/1898 (0.4) 6/918 (0.7)
Paternal tribe region of origin
            Central 751/1898 (39.1) 404/918 (44.0) 0.202
            Western 328/1898 (17.6) 172/918 (18.7)
            Eastern 385/1898 (20.6) 152/918 (16.6)
            Northern 201/1898 (10.3) 115/918 (12.5)
            Non-Ugandan 230/1898 (12.2) 71/918 (7.7)
            Do not know 3/1898 (0.2) 4/918 (0.4)
Treatment for worms
Ever treated for worms 1661/1896 (86.9) 646/888 (72.8) <0.001
Treated with albendazole in the last 12 months 1301/1597 (82.1) 480/641 (74.9) 0.666
Treated with praziquantel in the last 12 
months 1113/1604 (67.2) 19/639 (3.0) <0.001
Lake contact
Frequency of lake contact
            Every day 1309/1857 (67.5) 30/916 (3.3) <0.001
            Almost every day 297/1857 (16.3) 36/916 (3.9)
            Once a week 192/1857 (11.9) 44/916 (4.8)
            Once a month 52/1857 (3.8) 120/916 (13.1)
            Less than once a month 7/1857 (0.6) 686/916 (74.9)
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Household-level characteristics
Rural setting 
n/N (%)
Urban 
setting 
n/N (%)
P 
value*
Diabetes
History of diabetes
            Yes 7/1868 (0.5) 26/914 (2.8) <0.001
            No 1841/1868 (98.7) 808/914 (88.4)
            Do not know 20/1868 (0.9) 80/914 (8.8)
Hypertension
History of hypertension
            Yes 44/1868 (3.0) 77/914 (8.4) <0.001
            No 1815/1868 (96.5) 811/914 (88.7)
            Do not know 9/1868 (0.5) 26/914 (2.8)
Exercise
How often do you exercise / participate in 
vigorous physical activity
            Every day 28/1868 (1.4) 11/914 (1.2) <0.001
            Almost every day 396/1868 (21.1) 53/914 (5.8)
            Once a week 496/1868 (27.3) 88/914 (9.6)
            Once a month 372/1868 (18.7) 90/914 (9.9)
            Less than once a month 576/1868 (31.5) 672/914 (73.5)
History of smoking and alcohol intake
Ever smoked (either pipe or cigarette) 343/1868 (18.3) 38/914 (4.2) <0.001
Ever taken alcohol 905/1868 (47.5) 187/914 (20.5) <0.001
Helminth infections
Schistosoma mansoni, stool Kato Katz 440/1505 (31.7) 76/770 (9.9) <0.001
Schistosoma mansoni intensity, stool Kato Katz
Uninfected 1065/1505 (68.3) 694/770 (90.1) <0.001
Light 230/1505 (16.6) 36/770 (4.7)
Moderate 121/1505 (8.6) 27/770 (3.5)
Heavy 89/1505 (6.5) 13/770 (1.7)
Schistosoma mansoni, stool PCR 694/1487 (47.6) 171/771 (22.2) <0.001
Hookworm, stool Kato Katz 39/1505 (2.4) 25/769 (3.3) 0.308
Hookworm, stool PCR 55/1364 (3.7) 43/771 (5.6) 0.145
Trichuris trichiura, stool Kato Katz 122/1505 (6.9) 17/770 (2.2) 0.002
Ascaris lumbricoides, stool Kato Katz 3/1505 (0.2) 0 -
Mansonella perstans, modified Knott’s 20/1677 (1.1) 3/918 (0.3) 0.143
Strongyloides stercoralis, stool PCR 101/1486 (6.1) 25/771 (3.2) 0.026
Percentages adjusted for survey design; *P values obtained from survey design-based regression.
than in the urban setting (4.81 vs 4.71 mmol/L; adjusted mean 
difference -0.26 [95% confidence interval -0.40, -0.11] p=0.001). 
In unadjusted analyses and following adjustment for age and sex, 
no differences were seen in HOMA-IR. However, after further 
adjustment for BMI, exercise, alcohol intake and smoking, there 
was a negative mean difference suggesting higher HOMA-IR 
in the rural setting. The mean difference was most altered by 
adjusting for BMI. Following inclusion of HOMA-B as an 
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Figure 3. Variation of mean systolic and diastolic blood pressure with age in the rural and urban settings. The shaded areas 
represent 95% confidence intervals (allowing for clustering) around the mean systolic and diastolic blood pressure measurements for each 
age group.
additional outcome at the suggestion of a review, we found that 
individuals in the rural setting had lower (worse) pancreatic 
beta cell function than individuals in the urban setting even after 
adjusting for age, sex, exercise, alcohol intake, smoking and 
BMI (141.34 vs 201.72; 40.36 [8.00, 72.72] p=0.02].
Participants in the rural setting had significantly lower mean 
blood pressure than those in the urban setting even after adjust-
ment for sex, age, exercise, alcohol, smoking and BMI (systolic 
blood pressure, 114.21 vs 117.28 mmHg 5.45 [3.75, 7.15] 
p<0.001; diastolic blood pressure 75.81 vs 76.49 mmHg, 1.93 
[0.57, 3.29] p=0.006). These differences in blood pressure 
were more marked in the older age groups (Figure 3).
Participants in the rural setting had lower mean BMI than those 
in the urban setting. No differences were observed for waist 
circumference, waist-hip ratio, triglycerides, total cholesterol, 
LDL-cholesterol or HDL-cholesterol.
Despite having, on average, higher fasting glucose in the rural 
setting, there was no difference in the prevalence of diabetes 
between the rural and urban settings after adjusting for multiple 
potential confounders. However, the rural setting had a lower 
prevalence of hypertension (9.1% vs 13.4%, p=0.01) and obes-
ity (7.7% vs 14.0%, p<0.001), than the urban setting (Table 3 
and Table 4).
Helminth infection and intensity did not explain the rural urban 
differences observed for the metabolic parameters: very lit-
tle change was seen in the mean differences after further 
adjustment for helminth infection status or helminth infection 
intensity (Table 5).
Discussion
In this paper, we have shown that individuals in a rural, high 
helminth transmission setting had higher mean HOMA-
IR and fasting glucose, and lower pancreatic beta cell func-
tion than those in an urban low helminth transmission 
setting. They also had substantially lower blood pressure 
and BMI than their urban counterparts. This was not explained 
by differences in activity levels, age or sex or (for blood 
pressure) BMI and we did not find any impact of helminth 
infection on the observed rural-urban differences.
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In our relatively young study population, the prevalence of 
diabetes was low in both settings. It was surprising to find 
a higher mean fasting glucose and insulin resistance and 
lower pancreatic beta cell function in the rural setting. Although 
a higher diabetes prevalence in a rural setting compared to 
the urban setting has been reported in a study among 
secondary school students in Cameroon, there was no sig-
nificant difference in mean fasting glucose in that study35. One 
possible explanation for our finding is occupational. The major-
ity of our rural population is involved in fishing and fishing is 
mainly conducted at night. Night shift work has been associ-
ated with changes in the diurnal pattern of cortisol and conse-
quently predicts increased concentrations of cortisol36. Higher 
cortisol levels have been associated with raised plasma glu-
cose and insulin resistance37,38. Shift work has been linked to an 
increased risk of diabetes39, therefore, it is important to study 
how night time work in these rural fishing communities impacts 
metabolic health. Also, in view of their occupation, we cannot 
rule out the possibility that individuals in the rural setting were 
less adherent to the instructions on overnight fasting before 
the blood draw.
Another possible explanation is derived from the “thrifty phe-
notype hypothesis”, which proposes a link between poor fetal 
and early postnatal nutrition, and the development of T2D in 
adulthood40. This hypothesis proposes that malnutrition in early life 
impedes development of the pancreas making the pancreas more 
susceptible to development of diabetes. Therefore, individuals 
who have spent their early life in rural areas (as most of the rural 
survey participants had done in this study), where undernutrition 
is more common, are more prone to glucose dysregulation. 
The prevalence of hypertension was low in both settings. The 
rural environment was protective against hypertension, as sug-
gested by the lower mean blood pressure and lower hyperten-
sion prevalence. This is in agreement with previous findings in 
Uganda and the region41,42. Taking into account the higher levels 
of physical activity and lower BMI among the rural participants 
in our study did not alter the result, neither did adjusting for 
smoking and alcohol intake. This implies that other protective 
factors associated with the rural environment, not measured in 
our study, such as lower sodium intake43 and less pollution could 
be responsible for this. However, modernisation and change 
in household income may overturn the protective effects of the 
rural environment. For example, sodium intake in rural and urban 
Malawi is higher than the recommended amounts44. Studies to 
investigate the trends in cardiometabolic risk factors in rural 
environments such as the fishing communities we studied are 
therefore important.
The rural-urban differences we observed in glucose metabo-
lism, blood pressure and BMI could not be explained by the 
differences in current helminth prevalence. Given the existence 
of helminth infection in both settings, this is not surprising. The 
exposure to helminth infection in this particular urban setting 
(a peninsula, with easy access to the lake) was perhaps not 
low enough to eliminate helminth effects. Immunological 
changes induced by helminths can persist for long periods after 
clearance of the helminths45. Lifestyle factors and other envi-
ronmental exposures may be having a stronger influence on 
metabolic outcomes than helminths. However, investigat-
ing the role of helminths in the epidemiological transition still 
remains an important and interesting prospect worth pursu-
ing. Indeed, our previous LaVIISWA trial and observational 
analyses suggested that schistosomiasis infection was associ-
ated with lower serum total cholesterol and LDL-cholesterol 
levels and that moderate to heavy S. mansoni infection was asso-
ciated with lower triglycerides, LDL-cholesterol and diastolic 
blood pressure levels. Intensive anthelminthic treatment resulted 
in higher LDL-cholesterol levels, although helminths were 
still present in this intensively treated group, albeit with lower 
intensity than in residents of villages who received standard 
anthelminthic treatment22. Further work in an area with lower 
helminth prevalence is required to investigate this hypothesis.
The strengths of our project include the large sample size 
and the uniqueness of the study settings in relation to helminth 
prevalence. However, we were limited by the cross-sectional 
nature of the study and therefore cannot make causal inferences 
from the results, and cannot investigate the longevity, in the con-
text of lifestyle and epidemiological changes, of the observed 
differences. We performed multiple tests and did not formally 
correct for this, so cannot rule out chance findings, but all 
analyses were pre-planned and consistency between glucose and 
HOMA-IR and between diastolic and systolic blood pressure 
lend weight to the findings. Differences in socioeconomic sta-
tus and diet were not assessed and it is possible that these might 
partially explain differences between rural and urban settings. 
Fishing communities are rather unique rural communities in 
relation to housing, lifestyle, diet and exposure to schistosomiasis, 
and may not be representative of all rural communities.
In conclusion, our findings raise important questions about blood 
glucose and the rural environment. Is the rural environment 
potentially detrimental to glucose metabolism? Will the source 
of the next epidemic of diabetes be the rural areas even when 
the rural environment still remains associated with a better 
blood pressure and anthropometric profile?
Data availability
Underlying data
LSHTM Data compass: Contrasting impact of rural, versus urban, 
living on glucose metabolism and blood pressure in Uganda. 
https://doi.org/10.17037/DATA.0000152826.
This project contains the following underlying data:
• Rural-urban_survey_data.csv (individual-level rural- 
urban survey data).
• Rural-urban_survey_data_codebook.html (codebook for 
Rural-urban survey data; also lists all questions asked 
of study participants).
Data are available under the terms of the Creative Commons 
Attribution 3.0 International license (CC-BY 3.0).
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In the present manuscript, Sanya et al. have conducted a cross-sectional study comparing various 
metabolic parameters in both rural and urban communities in Uganda for investigating the 
potential impact of helminth infection and living environment on cardiometabolic diseases. 
Altogether, after multiple adjustments, they found that individuals living in rural environment 
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have a lower blood pressure than urban ones, as previously reported in other studies conducted 
in different countries, but a surprisingly higher fasting glucose levels and HOMA-IR despite lower 
incidence of type 2 diabetes. Helminth infection seems not to have any significant impact on all 
these parameters but, as acknowledged by the authors, individuals living in urban environment 
have a rather high rates of infection/treatment with anthelmintic drugs, suggesting that previous 
exposure might have already triggered/imprinted some immune response potentially beneficial 
for metabolic homeostasis. 
  
The design of the study is solid and the large sample size available, together with subtle diagnosis 
of helminths infection, is clearly one of the strength of such approach. The main weakness relies 
on the significant differences in gender and age distribution between rural and urban 
communities, especially for young participants (<19 year-old; 11.8% versus 28%, respectively; 
p<0.001). I’d have been curious to see whether the main outcomes were still present if the 
analyses have been systematically done only in adults. 
  
I have some minor comments/questions:
I’d suggest reporting the raw data for BMI and fasting insulin levels (used to calculate 
HOMA-IR) in Table 1 and 2, respectively. 
 
○
To try explaining the counterintuitive higher fasting glucose levels in individuals living in 
rural environment, the authors suggested that early life malnutrition in such population 
might affect pancreas development and predispose to metabolic dysfunctions. As such, it 
would have been interesting to calculate HOMA-B (20 × fasting insulin (μIU/ml)/fasting 
glucose (mmol/ml) − 3.5), which is a widely used index for assessing pancreatic beta cell 
function in humans. 
 
○
The discussion around the impact of disturbances in circadian rhythms, notably of cortisol 
levels, on glucose homeostasis due to nocturnal fishing activities in rural communities is 
definitely relevant. But it also raises a question about the eventual compliance to fasting for 
blood collection in such conditions. Could the authors provide a bit more information about 
the nutritional guidelines provided to the subjects prior to blood collection (last meal, sugar 
beverages…)? Same thing concerning the moment of the day where the blood pressure was 
measured. 
 
○
I’m not sure the term “impair glucose metabolism” used in the conclusion of the abstract is 
the most appropriate since both fasting plasma glucose levels and HOMA-IR, although 
higher in individuals living in rural than urban areas, are still far from the pathological 
ranges.
○
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The authors thank the reviewer for the comments on the manuscript and respond as 
follows. 
  
Comment: In the present manuscript, Sanya et al. have conducted a cross-sectional study 
comparing various metabolic parameters in both rural and urban communities in Uganda 
for investigating the potential impact of helminth infection and living environment on 
cardiometabolic diseases. Altogether, after multiple adjustments, they found that 
individuals living in rural environment have a lower blood pressure than urban ones, as 
previously reported in other studies conducted in different countries, but a surprisingly 
higher fasting glucose levels and HOMA-IR despite lower incidence of type 2 diabetes. 
Helminth infection seems not to have any significant impact on all these parameters but, as 
acknowledged by the authors, individuals living in urban environment have a rather high 
rates of infection/treatment with anthelmintic drugs, suggesting that previous exposure 
might have already triggered/imprinted some immune response potentially beneficial for 
metabolic homeostasis. 
  
The design of the study is solid and the large sample size available, together with subtle 
diagnosis of helminths infection, is clearly one of the strength of such approach. The main 
weakness relies on the significant differences in gender and age distribution between rural 
and urban communities, especially for young participants (<19 year-old; 11.8% versus 28%, 
respectively; p<0.001). I’d have been curious to see whether the main outcomes were still 
present if the analyses have been systematically done only in adults. 
  
Response: Following the reviewer’s suggestion, we did the analysis only in adults (table 3) 
and still found the differences in blood pressure and BMI. However, the differences in 
fasting glucose and HOMA-IR were less apparent, albeit with wider confidence intervals due 
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to the reduction in sample size. 
  
Comment: I have some minor comments/questions:  
Comment: I’d suggest reporting the raw data for BMI and fasting insulin levels (used to 
calculate HOMA-IR) in Table 1 and 2, respectively. 
 
Response: Data on the mean BMI in both populations are reported in table 2 and on the 
weight categories classified according to BMI in table 4. In the revised version of the 
manuscript, we have included the mean insulin levels in table 2. 
  
Comment: To try explaining the counterintuitive higher fasting glucose levels in individuals 
living in rural environment, the authors suggested that early life malnutrition in such 
population might affect pancreas development and predispose to metabolic dysfunctions. 
As such, it would have been interesting to calculate HOMA-B (20 × fasting insulin (μ
IU/ml)/fasting glucose (mmol/ml) − 3.5), which is a widely used index for assessing 
pancreatic beta cell function in humans. 
 
Response: We calculated the mean pancreatic beta cell function in the two populations 
using the formula above. We found that individuals in the urban setting had higher (better) 
pancreatic beta cell function (HOMA-B) than individuals in the rural setting even after 
adjusting for age, sex, exercise, alcohol intake, smoking and BMI (141.34 vs  201.72; 
adjusted mean difference 40.36 [95% confidence interval 8.00, 72.72] p= 0.02). This has been 
included in the revised manuscript. 
 
Comment: The discussion around the impact of disturbances in circadian rhythms, notably 
of cortisol levels, on glucose homeostasis due to nocturnal fishing activities in rural 
communities is definitely relevant. But it also raises a question about the eventual 
compliance to fasting for blood collection in such conditions. Could the authors provide a bit 
more information about the nutritional guidelines provided to the subjects prior to blood 
collection (last meal, sugar beverages…)? Same thing concerning the moment of the day 
where the blood pressure was measured. 
 
Response: The discussion has been revised to include the possibility of non-compliance to 
overnight fasting. However, all participants were told to fast from food and drink overnight 
for at least 8 hours and not to exercise or smoke before sample collection in the morning. 
Plain water could be consumed as much and as often as desired. 
 
Comment: I’m not sure the term “impair glucose metabolism” used in the conclusion of the 
abstract is the most appropriate since both fasting plasma glucose levels and HOMA-IR, 
although higher in individuals living in rural than urban areas, are still far from the 
pathological ranges. 
 
Response: We have revised the conclusion to reflect this.  
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Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Michael D. Gurven   
Department of Anthropology, University of California, Santa Barbara, Santa Barbara, CA, USA 
This large-scale cross-sectional study compares urban and rural Ugandans in several measures of 
cardiometabolic health risk. It highlights one salient aspect of many rural environments - intestinal 
helminthic infections - to test whether having helminths is associated with better cardiometabolic 
health. This follows from a small but growing literature that has proposed the intriguing 
hypothesis that helminths might offer protection against insulin resistance, hypercholesterolemia, 
hypertension and other factors underlying diabetes and atherosclerosis risk. While the authors 
find urban-rural differences in the majority of health outcomes, they do not find any evidence that 
helminths mediate these differences. 
 
As the authors indicate, helminth infection is highly prevalent in both rural and urban settings, 
and so there is no helminth-free control comparison. While helminths do not explain any urban-
rural differences in cardiometabolic health, it is possible that helminth infection is still associated 
with lower blood glucose, lower blood pressure and other health variables – just that these effects 
are similar across the urban-rural divide. Those analyses are not reported here. But a prior paper 
by this same research team working in Uganda (Sanya et al. 20191) does a better job of directly 
testing the helminth hypothesis by comparing those who received a standard antihelminth 
treatment with those receiving a more intensive pharmacological treatment regime. While that 
paper also did not have a helminth-free control, it did show that more frequent antihelminth 
treatment resulted in lower LDL and total cholesterol. Having a heavier Schistosoma mansoni 
infectious burden was also associated with lower blood triglyceride levels and lower diastolic 
blood pressure. It is curious that these rich findings by the same team are not highlighted or 
contextualized in the current study. 
 
I wonder if the Kato Katz analysis of infection intensity gives any more traction than the binary 
presence/absence used in the paper. Given most people have low-level burden, is it the case that 
protective effects are more evident among those with heavier burden? Given the cross-sectional 
nature of the database, however, those with heavier worm burden may have other health deficits 
or be living under more resource-poor and compromised setting. Additional controls for 
socioeconomic status may help adjust for potential confounding. 
 
As for the urban-rural health differences, the authors show that urban areas have higher diabetes 
risk (but lower fasting blood glucose), and higher prevalence of hypertension and obesity – though 
it is worth noting that overall prevalence of these conditions is low in both settings, and that ~77% 
of their sample consists of people under age 40. Perhaps due to the small absolute differences 
between setting, they find no urban-rural differences in metabolic syndrome—itself just a 
combination of the other cardiometabolic biomarkers. 
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The emphasis on urban-rural health differences is a useful starting point, but itself does not 
explain much, and may not generalize to other regions or countries. The authors conclude in the 
Abstract: “In low-income countries, rural living may protect against hypertension but impair 
glucose metabolism”. What is the basis for making such a broad generalization? “Urban” or “rural” 
are proxies for a cluster of traits that directly impact health, including diet, lifestyle differences 
(e.g. alcohol, smoking), physical activity, infection, social cohesion, pollution exposure, and the 
like. In the Ugandan context here, there are some patterns that do not generalize to many other 
urban-rural comparisons. For example, smoking and alcohol consumption appear to be more 
common in the rural than the urban context. Underweight is more prevalent in the urban setting, 
and this urban setting has lower but non-trivial prevalence of infection by several helminth 
species. These characteristics will vary widely across regions and countries. In order to generalize 
you would expect to find consistent differences across the key domains relevant to 
cardiometabolic disease: diet, physical activity, lifestyle, infection, etc. 
 
Given that urban-rural health differences still exist in their fully adjusted models, what can one 
conclude as to why? The first possibility is what might be missing from the adjusted models. The 
most obvious missing variable(s) reflect diet. It was a shame that diet was not assessed (or even 
described in a general way), including additives like sugar, salt and oil, and consumption of 
processed foods and beverages. Physical activity was also not measured directly, though 
participants were asked about “exercise and vigorous activity”. Exercise may be construed as a bit 
of a luxury, and vigorous activity is indicative but may not be the most relevant for comparison. 
What is more telling is how much moderate activity vs. sedentary activity people engage in 
through their daily activities – not restricted to leisure or exercise. Even without activity directly 
measured (e.g. with accelerometry), it’s possible that occupation might give a better indication of 
habitual activity than the interview question on exercise/vigorous activity. Perhaps adjustment for 
livelihood would contribute towards explaining (at least statistically) the urban-rural health 
differences. 
 
Another question is how long the current differences between urban and rural contexts have 
existed? If some lifestyle changes are recent, there might be greater health differences across 
urban-rural contexts among the younger cohorts. In this case, there would be an interaction 
between age cohort and urban-rural difference. Similarly, is there a sex difference in exposures 
due to how modernization manifests? I noticed that the urban sample was much more female-
biased, suggesting male out-migration or wage labor leading to greater male absenteeism. 
 
The authors mention the thrifty phenotype as a possible explanation for why people in the rural 
areas might be prone to glucose dysregulation. Thrifty phenotype and developmental origins of 
health and disease (DOHaD) paradigms emphasize the effects of early life exposures on later life 
chronic disease risk, especially when conditions shift over the life course (e.g. from harsh to 
abundant). That one-third of those living in the urban context were born and spent their first five 
years of life in a rural area permits one to explore the potential effects of developmental plasticity. 
A “purer” urban-rural contrast would be limited to those who spent their entire lives in the same 
environmental context. An additional exploration could test whether those who spent their early 
life in a rural context but now live in an urban context show worse cardiometabolic health than 
those who have spent their entire lives in a rural context. The authors have the data to make these 
comparisons, but do not include these early life variables in any analyses other than sample 
description (Table 1). 
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Lastly, while the authors speculate that sleep disruption and altered circadian rhythms might 
explain the surprising finding that fasting glucose is higher in the rural context, a simpler (but less 
interesting) possibility is that people in a rural context may be less likely to adhere to the 
requirement of an overnight fast prior to blood draw (especially if as noted, night fishing is a 
common activity in the rural setting). In the future, glycosylated hemoglobin (HbA1c) could be 
measured to provide a more reliable, long-term indicator of glucose levels. 
 
Also, although maybe less relevant, it was unclear whether there are ethnic differences within or 
between sampling areas that might reflect genetic differences underlying health risk. 
 
Overall, this is a nice epidemiological study highlighting imminent chronic disease risks in Uganda, 
showcasing that such risks are not restricted to urban areas. Prevalence rates of hypertension and 
central obesity are noteworthy in both urban and rural contexts. 
  
Minor: 
Given lower response rate due to absenteeism in the urban sample, are absent individuals more 
or less likely to show any health differences than those at home (e.g. more involved in wage labor, 
and perhaps more integrated into market economy)? If data exist for only one round of data 
collection then maybe this potential for bias cannot be checked. 
 
Any current use of medications, e.g. for hypertension? If so, are those individuals excluded from 
analyses of biomarkers? 
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I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
Author Response 18 Aug 2020
Richard Sanya, Medical Research Council/ Uganda Virus Research Institute and London 
School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda 
The authors thank the reviewer for the comments on the manuscript and respond as 
follows. 
  
Comment: This large-scale cross-sectional study compares urban and rural Ugandans in 
several measures of cardiometabolic health risk. It highlights one salient aspect of many 
rural environments - intestinal helminthic infections - to test whether having helminths is 
associated with better cardiometabolic health. This follows from a small but growing 
literature that has proposed the intriguing hypothesis that helminths might offer protection 
against insulin resistance, hypercholesterolemia, hypertension and other factors underlying 
diabetes and atherosclerosis risk. While the authors find urban-rural differences in the 
majority of health outcomes, they do not find any evidence that helminths mediate these 
differences. 
 
As the authors indicate, helminth infection is highly prevalent in both rural and urban 
settings, and so there is no helminth-free control comparison. While helminths do not 
explain any urban-rural differences in cardiometabolic health, it is possible that helminth 
infection is still associated with lower blood glucose, lower blood pressure and other health 
variables – just that these effects are similar across the urban-rural divide. Those analyses 
are not reported here. But a prior paper by this same research team working in Uganda 
(Sanya et al. 20191) does a better job of directly testing the helminth hypothesis by 
comparing those who received a standard antihelminth treatment with those receiving a 
more intensive pharmacological treatment regime. While that paper also did not have a 
helminth-free control, it did show that more frequent antihelminth treatment resulted in 
lower LDL and total cholesterol. Having a heavier Schistosoma mansoni infectious burden 
was also associated with lower blood triglyceride levels and lower diastolic blood pressure. 
It is curious that these rich findings by the same team are not highlighted or contextualized 
in the current study. 
  
Response: Thank you for this suggestion. We agree that helminth infection may still be 
associated with lower blood glucose and other health variables. Following the reviewer’s 
suggestion, in the new version of the manuscript, we have incorporated our previous 
findings into the fifth paragraph of the discussion, and highlight that the potential role of 
helminths in the epidemiological transition merits further investigation. 
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Comment: I wonder if the Kato Katz analysis of infection intensity gives any more traction 
than the binary presence/absence used in the paper. Given most people have low-level 
burden, is it the case that protective effects are more evident among those with heavier 
burden? Given the cross-sectional nature of the database, however, those with heavier 
worm burden may have other health deficits or be living under more resource-poor and 
compromised setting. Additional controls for socioeconomic status may help adjust for 
potential confounding. 
  
Response: Thank you for this suggestion. We have redone the analysis and included S. 
mansoni infection intensity in the revised manuscript (Table 5). S. mansoni infection intensity 
did not explain  the rural-urban differences, and we have expanded the text in the last 
paragraph of the results section to include this finding. Unfortunately, we did not collect 
data on socio-economic status in the metabolic survey conducted in the rural setting and 
were therefore unable to adjust for it in this analysis. We now state this in the discussion 
(paragraph 6) as a limitation of the study. 
  
Comment: As for the urban-rural health differences, the authors show that urban areas 
have higher diabetes risk (but lower fasting blood glucose), and higher prevalence of 
hypertension and obesity – though it is worth noting that overall prevalence of these 
conditions is low in both settings, and that ~77% of their sample consists of people under 
age 40. Perhaps due to the small absolute differences between setting, they find no urban-
rural differences in metabolic syndrome—itself just a combination of the other 
cardiometabolic biomarkers. 
  
Response: Thank you for pointing this out. The overall prevalence of diabetes and 
hypertension was low in both settings and the majority of the population was young. We 
have now highlighted the relatively young study population (representative of the country 
as a whole) in the discussion. We had previously stated in the discussion that the prevalence 
of diabetes was low in both settings, but have now included a similar statement about 
hypertension in the revised manuscript. 
  
Comment: The emphasis on urban-rural health differences is a useful starting point, but 
itself does not explain much, and may not generalize to other regions or countries. The 
authors conclude in the Abstract: “In low-income countries, rural living may protect against 
hypertension but impair glucose metabolism”. What is the basis for making such a broad 
generalization? “Urban” or “rural” are proxies for a cluster of traits that directly impact 
health, including diet, lifestyle differences (e.g. alcohol, smoking), physical activity, infection, 
social cohesion, pollution exposure, and the like. In the Ugandan context here, there are 
some patterns that do not generalize to many other urban-rural comparisons. For example, 
smoking and alcohol consumption appear to be more common in the rural than the urban 
context. Underweight is more prevalent in the urban setting, and this urban setting has 
lower but non-trivial prevalence of infection by several helminth species. These 
characteristics will vary widely across regions and countries. In order to generalize you 
would expect to find consistent differences across the key domains relevant to 
cardiometabolic disease: diet, physical activity, lifestyle, infection, etc. 
 
Response: We appreciate the reviewer’s point and have refined the conclusion to make it 
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more specific. It now reads “In the Ugandan context, living in rural fishing communities may 
protect against hypertension but worsen glucose metabolism”. 
  
Comment: Given that urban-rural health differences still exist in their fully adjusted models, 
what can one conclude as to why? The first possibility is what might be missing from the 
adjusted models. The most obvious missing variable(s) reflect diet. It was a shame that diet 
was not assessed (or even described in a general way), including additives like sugar, salt 
and oil, and consumption of processed foods and beverages. Physical activity was also not 
measured directly, though participants were asked about “exercise and vigorous activity”. 
Exercise may be construed as a bit of a luxury, and vigorous activity is indicative but may 
not be the most relevant for comparison. What is more telling is how much moderate 
activity vs. sedentary activity people engage in through their daily activities – not restricted 
to leisure or exercise. Even without activity directly measured (e.g. with accelerometry), it’s 
possible that occupation might give a better indication of habitual activity than the interview 
question on exercise/vigorous activity. Perhaps adjustment for livelihood would contribute 
towards explaining (at least statistically) the urban-rural health differences. 
  
Response: In the second last paragraph of the discussion, we acknowledged the absence of 
data on diet as a limitation and have stated, in the revised manuscript, that the differences 
in the rural and urban settings may be partially explained by diet and socio-economic 
status, and that not being able to adjust for these factors is a limitation of the study. 
Following the reviewer’s suggestion, we have redone the analysis and added occupation as 
a possible proxy for activity levels to the adjusted models. No major differences were 
observed between the findings from the adjusted model and those in the previous model 
without the occupation variable. The results of the adjusted model are presented in the new 
version of the manuscript.  
  
Comment: Another question is how long the current differences between urban and rural 
contexts have existed? If some lifestyle changes are recent, there might be greater health 
differences across urban-rural contexts among the younger cohorts. In this case, there 
would be an interaction between age cohort and urban-rural difference. Similarly, is there a 
sex difference in exposures due to how modernization manifests? I noticed that the urban 
sample was much more female-biased, suggesting male out-migration or wage labor 
leading to greater male absenteeism. 
 
 
Response: Thank you for this. In view of the cross-sectional nature of the study design, we 
were unable to determine how long the current differences in metabolic parameters 
between the rural and urban contexts have existed and to our knowledge, no study has 
previously assessed the urban-rural differences in metabolic outcomes in these 
populations. The rural population in particular is highly mobile, with only 9% having lived 
there all their lives (Table 1), therefore examining for an interaction between age cohort and 
urban-rural differences may not be informative.  We have expanded our discussion to 
highlight these consequences of the cross-sectional study design. 
 
Comment: The authors mention the thrifty phenotype as a possible explanation for why 
people in the rural areas might be prone to glucose dysregulation. Thrifty phenotype and 
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developmental origins of health and disease (DOHaD) paradigms emphasize the effects of 
early life exposures on later life chronic disease risk, especially when conditions shift over 
the life course (e.g. from harsh to abundant). That one-third of those living in the urban 
context were born and spent their first five years of life in a rural area permits one to 
explore the potential effects of developmental plasticity. A “purer” urban-rural contrast 
would be limited to those who spent their entire lives in the same environmental context. 
An additional exploration could test whether those who spent their early life in a rural 
context but now live in an urban context show worse cardiometabolic health than those 
who have spent their entire lives in a rural context. The authors have the data to make these 
comparisons, but do not include these early life variables in any analyses other than sample 
description (Table 1). 
 
 
Response: Exploring the potential effects of plasticity on the metabolic outcomes and the 
“purer” rural-urban contrast limited to those who spent their entire lives in the same 
environmental context are excellent suggestions. However, these analyses were not 
preplanned and the surveys were not powered to measure them. With that in mind, we 
have performed this posthoc analysis and the results are shown in tables 1 and 2. We did 
not find differences in HOMA-IR and fasting glucose between individuals in the urban 
environment who spent their entire lives in the urban environment and those who were 
born and lived in the rural environment for the first five years and later moved to the urban 
environment (table 1). 
 
For the “purer” rural-urban analysis limited to individuals who spent their entire lives in the 
same environment (table 2), we still found differences in fasting glucose and blood 
pressure, as in the main analysis. However, the difference in HOMA-IR, observed in the main 
analysis was lost here. 
The number of individuals analysed was far smaller than in the main analysis, and this 
cannot be ruled out as a reason for the discrepancy in the two findings. However, we do 
appreciate the input and will factor this in when designing rural-urban comparison studies 
in the future. 
 
Comment: Lastly, while the authors speculate that sleep disruption and altered circadian 
rhythms might explain the surprising finding that fasting glucose is higher in the rural 
context, a simpler (but less interesting) possibility is that people in a rural context may be 
less likely to adhere to the requirement of an overnight fast prior to blood draw (especially if 
as noted, night fishing is a common activity in the rural setting). In the future, glycosylated 
hemoglobin (HbA1c) could be measured to provide a more reliable, long-term indicator of 
glucose levels. 
 
Response: Thank you for this suggestion - we have revised the manuscript to include this 
possibility. 
 
Comment: Also, although maybe less relevant, it was unclear whether there are ethnic 
differences within or between sampling areas that might reflect genetic differences 
underlying health risk. 
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Response: There were no ethnic differences between the sampling areas. This is shown in 
table 1 where reference is made to parental tribe. 
 
Comment: Overall, this is a nice epidemiological study highlighting imminent chronic 
disease risks in Uganda, showcasing that such risks are not restricted to urban areas. 
Prevalence rates of hypertension and central obesity are noteworthy in both urban and 
rural contexts. 
 
Minor: 
Comment: Given lower response rate due to absenteeism in the urban sample, are absent 
individuals more or less likely to show any health differences than those at home (e.g. more 
involved in wage labor, and perhaps more integrated into market economy)? If data exist 
for only one round of data collection then maybe this potential for bias cannot be checked. 
 
Response: Unfortunately, there was only one urban survey. We did not explore the health 
differences between individuals who were present at home and those absent because the 
individual questionnaires used to capture these data were only administered to participants 
who were present. 
 
Comment: Any current use of medications, e.g. for hypertension? If so, are those 
individuals excluded from analyses of biomarkers? 
  
Response: Current use of medications especially for hypertension, was uncommon and 
therefore these individuals were not excluded from the analysis.  
Competing Interests: No competing interests were disclosed.
 
Page 29 of 29
Wellcome Open Research 2020, 5:39 Last updated: 25 AUG 2020
